Cowen Starts Sophia Genetics SA (SOPH) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
UPDATE: Credit Suisse Starts Sophia Genetics SA (SOPH) at Outperform
August 17, 2021 4:27 AM EDT(Updated - August 17, 2021 4:43 AM EDT)
Credit Suisse analyst Katie Tryhane initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Outperform rating and a price target of $22.00.
The analyst comments "SOPH is a healthcare technology company offering a decentralized software platform that leverages... More
JPMorgan Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 4:20 AM EDTJPMorgan analyst Tycho W. Peterson initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Sophia Genetics SA... More
UPDATE: Morgan Stanley Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 3:31 AM EDT(Updated - August 17, 2021 4:41 AM EDT)
Morgan Stanley analyst Tejas Savant initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $24.00.
The analyst comments "Riding on the coattails of healthcare digitization, SOPHs differentiated... More
